Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,364 GBX | +0.37% | +1.91% | +16.51% |
13/05 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
13/05 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.51% | 240B | |
+29.98% | 682B | |
+31.81% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+9.40% | 209B | |
-8.79% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Discontinues Two Phase 3 Evidence Trials of Lokelma in Managing Hyperkalemia